Bloomberg Billionaires Index

View profiles for each of the world’s 500 richest people, see the biggest movers, and compare fortunes or track returns.

# 339 Cen Junda $7.10B

Random fact: China has the world's largest number of cancer cases.


Cen is a shareholder of Jiangsu Hengrui Medicine, a Chinese producer of anti-cancer drugs. The company develops anti-tumor, anti-infective and painkiller drugs, and had revenue of 25.9 billion yuan ($4 billion) in 2021. He also owns a stake in Hansoh Pharmaceutical Group, a drug maker that trades publicly in Hong Kong.

As of :
Last change +$21.8M ( +0.3%)
YTD change +$1.08B ( +17.9%)
Biggest asset 600276 CH Equity
Country / Region China
Age 58
Industry Health Care
View net worth over:   Max 1 year 1 quarter 1 month 1 week

Relative Value

Cen Junda's net worth of $7.10B can buy ...

troy ounces of gold
barrels of crude oil

... and is equivalent to ...

of the GDP of the United States
of the total wealth of the 500 richest people in the world
of the top 100 U.S. college endowments
of the top 200 U.S. executives’ total awarded compensation
of U.S. existing home sales
times the median U.S. household income

Latest News

Net Worth Summary

Private asset
Public asset
Misc. liabilities
Confidence rating:

The majority of Cen's wealth is derived from his 17% stake in Jiangsu Hengrui Medicine, a Chinese manufacturer of anti-cancer medicines. He owns his stake through a holding company, according to the company's 2022 third-quarter report.

Cen also has a 15% stake in Hansoh Pharmaceutical Group, according to the company's 2022 semi-annual report.

Liu Xiaohan, spokeswoman for the company, declined to comment on the billionaire's net worth.


Family: Unknown, No children

Cen graduated from Zhejiang University majoring in pharmaceuticals in 1984.

His holding company Apex Medical was a founding shareholder of Hansoh Pharmaceutical Group in 2015, according to the company's prospectus for an initial public offering.

The company began publicly trading in Hong Kong in June 2019. Cen and Zhong Huijuan, chairwoman of the drug maker, are billionaires.

  • 1995 Hansoh Pharmaceutical was set up in China.
  • 2000 Jiangsu hengrui started publicly trading in Shanghai.
  • 2011 U.S. approves Jiangsu Hengrui's antineoplastic injection.
  • 2019 Hansoh Pharmaceutical started trading in Hong Kong.